Aethlon Medical Stock EBITDA

AEMD Stock  USD 1.71  0.04  2.29%   
Aethlon Medical fundamentals help investors to digest information that contributes to Aethlon Medical's financial success or failures. It also enables traders to predict the movement of Aethlon Stock. The fundamental analysis module provides a way to measure Aethlon Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aethlon Medical stock.
The current year's EBITDA is expected to grow to about (10.1 M).
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Aethlon EBITDA Analysis

Aethlon Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Aethlon Medical Ebitda

(10.05 Million)

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Aethlon Medical EBITDA

    
  (11.76 M)  
Most of Aethlon Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aethlon Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Aethlon EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Aethlon Medical is extremely important. It helps to project a fair market value of Aethlon Stock properly, considering its historical fundamentals such as EBITDA. Since Aethlon Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aethlon Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aethlon Medical's interrelated accounts and indicators.
-0.290.9-0.94-0.790.92-0.241.0-0.32-0.02-0.89-0.410.13-0.480.13-0.520.880.740.920.850.790.39-0.410.870.840.05
-0.29-0.660.410.23-0.330.95-0.30.930.420.460.85-0.110.2-0.120.57-0.2-0.13-0.59-0.44-0.460.150.65-0.19-0.170.05
0.9-0.66-0.94-0.720.85-0.640.91-0.7-0.28-0.92-0.750.09-0.520.2-0.750.740.70.980.870.850.22-0.650.740.71-0.02
-0.940.41-0.940.81-0.860.43-0.960.490.20.90.57-0.030.48-0.280.68-0.71-0.78-0.94-0.88-0.88-0.380.52-0.82-0.80.11
-0.790.23-0.720.81-0.930.23-0.80.290.230.580.410.440.37-0.250.49-0.6-0.7-0.85-0.82-0.89-0.210.67-0.61-0.570.04
0.92-0.330.85-0.86-0.93-0.280.91-0.36-0.15-0.75-0.48-0.2-0.50.15-0.550.810.750.930.870.850.21-0.640.70.660.08
-0.240.95-0.640.430.23-0.28-0.260.980.60.470.950.020.3-0.210.74-0.1-0.26-0.56-0.44-0.520.170.71-0.14-0.130.13
1.0-0.30.91-0.96-0.80.91-0.26-0.34-0.05-0.89-0.420.1-0.470.17-0.540.840.750.920.870.80.4-0.420.860.840.0
-0.320.93-0.70.490.29-0.360.98-0.340.630.530.970.030.29-0.210.76-0.17-0.33-0.62-0.5-0.570.150.73-0.21-0.190.13
-0.020.42-0.280.20.23-0.150.6-0.050.630.140.680.480.27-0.210.520.18-0.46-0.26-0.43-0.44-0.010.560.190.220.11
-0.890.46-0.920.90.58-0.750.47-0.890.530.140.61-0.320.68-0.060.69-0.81-0.74-0.85-0.77-0.72-0.370.39-0.79-0.75-0.11
-0.410.85-0.750.570.41-0.480.95-0.420.970.680.610.140.48-0.210.87-0.26-0.51-0.69-0.59-0.650.140.81-0.23-0.210.1
0.13-0.110.09-0.030.44-0.20.020.10.030.48-0.320.14-0.03-0.210.170.3-0.23-0.07-0.15-0.310.280.550.290.30.23
-0.480.2-0.520.480.37-0.50.3-0.470.290.270.680.48-0.030.190.6-0.55-0.72-0.46-0.52-0.47-0.220.32-0.3-0.24-0.37
0.13-0.120.2-0.28-0.250.15-0.210.17-0.21-0.21-0.06-0.21-0.210.19-0.29-0.170.250.210.320.360.22-0.130.020.03-0.73
-0.520.57-0.750.680.49-0.550.74-0.540.760.520.690.870.170.6-0.29-0.36-0.66-0.69-0.59-0.70.130.75-0.4-0.390.16
0.88-0.20.74-0.71-0.60.81-0.10.84-0.170.18-0.81-0.260.3-0.55-0.17-0.360.550.740.620.540.24-0.270.80.760.41
0.74-0.130.7-0.78-0.70.75-0.260.75-0.33-0.46-0.74-0.51-0.23-0.720.25-0.660.550.70.820.770.45-0.440.470.43-0.08
0.92-0.590.98-0.94-0.850.93-0.560.92-0.62-0.26-0.85-0.69-0.07-0.460.21-0.690.740.70.90.890.2-0.710.740.71-0.03
0.85-0.440.87-0.88-0.820.87-0.440.87-0.5-0.43-0.77-0.59-0.15-0.520.32-0.590.620.820.90.870.42-0.560.550.51-0.12
0.79-0.460.85-0.88-0.890.85-0.520.8-0.57-0.44-0.72-0.65-0.31-0.470.36-0.70.540.770.890.870.33-0.70.660.62-0.04
0.390.150.22-0.38-0.210.210.170.40.15-0.01-0.370.140.28-0.220.220.130.240.450.20.420.330.390.360.330.01
-0.410.65-0.650.520.67-0.640.71-0.420.730.560.390.810.550.32-0.130.75-0.27-0.44-0.71-0.56-0.70.39-0.23-0.210.05
0.87-0.190.74-0.82-0.610.7-0.140.86-0.210.19-0.79-0.230.29-0.30.02-0.40.80.470.740.550.660.36-0.231.00.21
0.84-0.170.71-0.8-0.570.66-0.130.84-0.190.22-0.75-0.210.3-0.240.03-0.390.760.430.710.510.620.33-0.211.00.17
0.050.05-0.020.110.040.080.130.00.130.11-0.110.10.23-0.37-0.730.160.41-0.08-0.03-0.12-0.040.010.050.210.17
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

Aethlon Ebitda

Ebitda

(10.05 Million)

At present, Aethlon Medical's EBITDA is projected to decrease significantly based on the last few years of reporting.
According to the company disclosure, Aethlon Medical reported earnings before interest,tax, depreciation and amortization of (11.76 Million). This is 101.34% lower than that of the Health Care Equipment & Supplies sector and 101.83% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.3% higher than that of the company.

Aethlon EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aethlon Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aethlon Medical could also be used in its relative valuation, which is a method of valuing Aethlon Medical by comparing valuation metrics of similar companies.
Aethlon Medical is currently under evaluation in ebitda category among related companies.

Aethlon Medical Institutional Holders

Institutional Holdings refers to the ownership stake in Aethlon Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aethlon Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aethlon Medical's value.
Shares
Bartlett & Co Wealth Management Llc2023-12-31
26.0
Susquehanna International Group, Llp2023-09-30
0.0
Mercer Global Advisors Inc.2023-09-30
0.0
Larson Financial Group, Llc2023-09-30
0.0
Virtu Financial Llc2023-09-30
0.0
Vanguard Group Inc2023-12-31
21.2 K
Geode Capital Management, Llc2023-12-31
20.3 K
Blackrock Inc2023-12-31
7.3 K
Group One Trading, Lp2023-12-31
1.3 K
Tower Research Capital Llc2023-12-31
1.1 K
Advisor Group Holdings, Inc.2023-12-31
299

Aethlon Fundamentals

About Aethlon Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Aethlon Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aethlon Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aethlon Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
EBITDA-10.6 M-10.1 M

Pair Trading with Aethlon Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aethlon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aethlon Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aethlon Stock

  0.61MBOT Microbot Medical Earnings Call TomorrowPairCorr
  0.71DYNT Dynatronics Financial Report 9th of May 2024 PairCorr

Moving against Aethlon Stock

  0.86NYXH Nyxoah Financial Report 21st of May 2024 PairCorr
  0.63FEMY Femasys Report 4th of April 2024 PairCorr
  0.62OMIC Singular Genomics Systems Financial Report 14th of May 2024 PairCorr
  0.59CAH Cardinal Health Financial Report 2nd of May 2024 PairCorr
  0.53NVNO EnVVeno Medical Corp Financial Report 6th of May 2024 PairCorr
The ability to find closely correlated positions to Aethlon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aethlon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aethlon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aethlon Medical to buy it.
The correlation of Aethlon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aethlon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aethlon Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aethlon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:
Check out Aethlon Medical Piotroski F Score and Aethlon Medical Altman Z Score analysis.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for Aethlon Stock analysis

When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.01)
Revenue Per Share
0.236
Quarterly Revenue Growth
42.782
Return On Assets
(0.47)
Return On Equity
(0.98)
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.